Research Article

VX765, a Specific Caspase-1 Inhibitor, Alleviates Lung Ischemia Reperfusion Injury by Suppressing Endothelial Pyroptosis and Barrier Dysfunction

Figure 5

The effects of caspase-1 inhibitor VX765 on lung injury and inflammation. (a–h) Mouse lung tissue and serum were collected from each group for the following experiments. (a) The pathology score was evaluated by H&E staining. Scale bar, 100 μm. (b) Lung damage was evaluated based on H&E images. (c) IL-6 mRNA levels measured by RT-qPCR. (d, e) IL-6 protein levels measured in lung and serum by ELISA. (f) TNF-α mRNA level measured by RT-qPCR. (g, h) TNF-α protein level in lung and serum measured by ELISA. The data are expressed as ( per group). . vs. control. # vs. I/R.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)